Business

USANA Health Sciences Provides Preliminary Third Quarter Results

SALT LAKE CITY, October 09, 2025--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the third quarter ended September 27, 2025. The Company anticipates third quarter 2025 net sales will be approximately $214 million, which compares with $200 million in the prior-year period. Earnings from operations are expected to be $1.2 million for the current-year quarter, or 0.6% of net sales, as compared to $15.6 million in the third quarter of 2024.

articleUsana Health Sciences, Inc.October 9, 202512/company/usana-health-sciences-inc/news/usana-health-sciences-provides-preliminary-200500484
USANA Health Sciences Provides Preliminary Third Quarter Results

About this update from Usana Health Sciences, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/4493cc8f6f789a028972c8b7f9a41b8a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/M51SdGEnOaDNuqkhlrG4QA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/4493cc8f6f789a028972c8b7f9a41b8a","width":480,"height":480}},"lazy":false},{"type":"text","content":"SALT LAKE CITY, October 09, 2025--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the third quarter ended September 27, 2025. The Company anticipates third quarter 2025 net sales will be approximately $214 million, which compares with $200 million in the prior-year period. Earnings from operations are expected to be $1.2 million for the current-year quarter, or 0.6% of net sales, as compared to $15.6 million in the third quarter of 2024.","length":491,"tagName":"p"},{"type":"text","content":""Third quarter operating results came in below expectations, primarily due to softer-than-expected sales and Brand Partner productivity during the rollout of our enhanced Brand Partner compensation plan," said Jim Brown, President and Chief Executive Officer. "While we expected a slowdown during this transition, it was more pronounced than anticipated and negatively affected our quarterly results. Additionally, Hiya, our direct-to-consumer business, delivered softer sales on lower than anticipated customer acquisition rates in a quarter that is typically seasonally strong. Nevertheless, we continue to expect Hiya to generate double-digit sales growth for 2025.","length":683,"tagName":"p"},{"type":"text","content":""Despite the short-term challenges, our enhanced compensation plan represents a bold and strategic move to modernize our business and better position our Brand Partners, and the Company, for long-term success in a competitive landscape," Brown continued. "Since announcing these changes, our commercial team has been actively training, educating and supporting Brand Partners across our global markets to help them leverage the new plan. Although it is still early, we are encouraged by our Brand Partners’ response to the enhancements and the recent pickup we ha...

More updates from Usana Health Sciences, Inc.

The CompanyBrand Partnersearnings per shareUSANApreliminary resultscompensation planJim BrownEBITDAincome tax ratenet earnings